Chapter 4
Scaling the Carbon Bridge: From Hope to Human Trials
The team begins planning the translation of the 3D Carbon Nanotube-Fullerene Hyper-Lattice from animal models to early human clinical trials. Dr. Thorne and Dr. Hanson review the rat data, noting positive trends alongside persistent issues of inflammation and immune response. Marcus Bellweather participates in preliminary assessments and interviews, representing future human recipients. The chapter covers the challenges of regulatory requirements, safety testing, and scaling the device for human anatomy. The team prepares grant proposals and faces new pressures from public interest. The chapter ends as Marcus and the researchers await word on whether the project will advance to official preclinical review.
The question grew sharper: Could the carbon lattice, successful in guiding rat nerves, be prepared for the far greater challenge of human spinal cords? As sunlight angled across the lab’s meeting table, Dr. Thorne scrolled through charts and heatmaps, the data vivid yet incomplete. Dr. Hanson tapped the edge of her tablet. “If we move forward, it’s not just about what happens in a rat. Human tissue is less forgiving.”
They began mapping the sequence of hurdles that awaited. The lattice would need to be fabricated at a scale several times larger, tailored to the unique geometry of human injuries. Its surfaces would have to resist scarring and minimize inflammation, a balance of chemistry both subtle and critical. For every step, regulators would demand rigorous demonstration: biocompatibility, sterility, non-toxicity, and durability over months, not weeks.
Marcus Bellweather wheeled into the conference room, a printout of the latest rat results on his lap. "People will want guarantees," he said, voice steady. “But what matters to me is a real chance—no matter how small.” His presence gave the project urgency beyond charts and graphs. Marcus participated in early psychological screening and physical assessments, answering detailed questionnaires about daily living, risks he’d be willing to accept, and hopes he harbored, quietly, behind his dry humor.
Keep reading "Scaling the Carbon Bridge: From Hope to Human Trials"
Open the same story in AIBookCraft. Later chapters may require an active subscription.
Free on iOS & Android · No signup to read